Anok Yai shared that she underwent lung surgery after a "silent" health battle uncovered a birth defect that was affecting ...

As we continue to document the many reasons for young heart attacks in the country, there are some less talked about triggers. About five years ago, I had a 35-year-old executive come into the ...

Passengers at Manchester Airport are facing lengthy delays due to bad weather and a runway closure this morning ...

Sahajanand Medical Technologies (SMT) is changing the face of congenital heart disease treatment through its innovative Cocoon Occluder devices. Targeting defects such as atrial septal defect and ...

Encore Medical, Inc. seeks $17.25 million in IPO funding to support US FDA trials for its heart defect closure device. EMI has CE Mark approval in the EU but limited recent sales; US clinical trial ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Flaherty & Crumrine Preferred Income Opportunity Fund remains a buy, offering a 6.3% yield and trading at a 6.54% discount to NAV. PFO provides diversified exposure to preferred securities, with a ...

Background: Conventional nickel-titanium patent foramen ovale (PFO) occluders hinder transseptal puncture due to septal obstruction, limiting access for left-heart interventions. To address this, we ...